These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 39079583)

  • 1. Crystal structure of the GluK1 ligand-binding domain with kainate and the full-spanning positive allosteric modulator BPAM538.
    Bay Y; Cabello FJM; Koens CC; Frantsen SM; Pickering DS; Frydenvang K; Francotte P; Pirotte B; Kristensen AS; Bowie D; Kastrup JS
    J Struct Biol; 2024 Sep; 216(3):108113. PubMed ID: 39079583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small-molecule positive allosteric modulation of homomeric kainate receptors GluK1-3: development of screening assays and insight into GluK3 structure.
    Bay Y; Venskutonytė R; Frantsen SM; Thorsen TS; Musgaard M; Frydenvang K; Francotte P; Pirotte B; Biggin PC; Kristensen AS; Boesen T; Pickering DS; Gajhede M; Kastrup JS
    FEBS J; 2024 Apr; 291(7):1506-1529. PubMed ID: 38145505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and Structure-Function Study of Positive Allosteric Modulators of Kainate Receptors.
    Larsen AP; Fièvre S; Frydenvang K; Francotte P; Pirotte B; Kastrup JS; Mulle C
    Mol Pharmacol; 2017 Jun; 91(6):576-585. PubMed ID: 28360094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kainate induces various domain closures in AMPA and kainate receptors.
    Venskutonytė R; Frydenvang K; Hald H; Rabassa AC; Gajhede M; Ahring PK; Kastrup JS
    Neurochem Int; 2012 Sep; 61(4):536-45. PubMed ID: 22425692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and Affinity of Two Bicyclic Glutamate Analogues at AMPA and Kainate Receptors.
    Møllerud S; Pinto A; Marconi L; Frydenvang K; Thorsen TS; Laulumaa S; Venskutonytė R; Winther S; Moral AMC; Tamborini L; Conti P; Pickering DS; Kastrup JS
    ACS Chem Neurosci; 2017 Sep; 8(9):2056-2064. PubMed ID: 28691798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The positive allosteric modulator BPAM344 and L-glutamate introduce an active-like structure of the ligand-binding domain of GluK2.
    Bay Y; Egeberg Jeppesen M; Frydenvang K; Francotte P; Pirotte B; Pickering DS; Kristensen AS; Kastrup JS
    FEBS Lett; 2024 Apr; 598(7):743-757. PubMed ID: 38369668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding site and interlobe interactions of the ionotropic glutamate receptor GluK3 ligand binding domain revealed by high resolution crystal structure in complex with (S)-glutamate.
    Venskutonytė R; Frydenvang K; Gajhede M; Bunch L; Pickering DS; Kastrup JS
    J Struct Biol; 2011 Dec; 176(3):307-14. PubMed ID: 21907808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Structure of a High-Affinity Kainate Receptor: GluK4 Ligand-Binding Domain Crystallized with Kainate.
    Kristensen O; Kristensen LB; Møllerud S; Frydenvang K; Pickering DS; Kastrup JS
    Structure; 2016 Sep; 24(9):1582-9. PubMed ID: 27524200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lessons from crystal structures of kainate receptors.
    Møllerud S; Frydenvang K; Pickering DS; Kastrup JS
    Neuropharmacology; 2017 Jan; 112(Pt A):16-28. PubMed ID: 27236079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding and selectivity of the marine toxin neodysiherbaine A and its synthetic analogues to GluK1 and GluK2 kainate receptors.
    Unno M; Shinohara M; Takayama K; Tanaka H; Teruya K; Doh-ura K; Sakai R; Sasaki M; Ikeda-Saito M
    J Mol Biol; 2011 Oct; 413(3):667-83. PubMed ID: 21893069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding mode of an α-amino acid-linked quinoxaline-2,3-dione analogue at glutamate receptor subtype GluK1.
    Demmer CS; Møller C; Brown PM; Han L; Pickering DS; Nielsen B; Bowie D; Frydenvang K; Kastrup JS; Bunch L
    ACS Chem Neurosci; 2015 Jun; 6(6):845-54. PubMed ID: 25856736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assembly and Trafficking of Homomeric and Heteromeric Kainate Receptors with Impaired Ligand Binding Sites.
    Scholefield CL; Atlason PT; Jane DE; Molnár E
    Neurochem Res; 2019 Mar; 44(3):585-599. PubMed ID: 30302614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping the ligand binding sites of kainate receptors: molecular determinants of subunit-selective binding of the antagonist [3H]UBP310.
    Atlason PT; Scholefield CL; Eaves RJ; Mayo-Martin MB; Jane DE; Molnár E
    Mol Pharmacol; 2010 Dec; 78(6):1036-45. PubMed ID: 20837679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlating efficacy and desensitization with GluK2 ligand-binding domain movements.
    Nayeem N; Mayans O; Green T
    Open Biol; 2013 May; 3(5):130051. PubMed ID: 23720540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for positive allosteric modulation of AMPA and kainate receptors.
    Frydenvang K; Pickering DS; Kastrup JS
    J Physiol; 2022 Jan; 600(2):181-200. PubMed ID: 33938001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The auxiliary subunits Neto1 and Neto2 have distinct, subunit-dependent effects at recombinant GluK1- and GluK2-containing kainate receptors.
    Fisher JL
    Neuropharmacology; 2015 Dec; 99():471-80. PubMed ID: 26277340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of critical functional determinants of kainate receptor modulation by auxiliary protein Neto2.
    Griffith TN; Swanson GT
    J Physiol; 2015 Nov; 593(22):4815-33. PubMed ID: 26282342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N1-Substituted Quinoxaline-2,3-diones as Kainate Receptor Antagonists: X-ray Crystallography, Structure-Affinity Relationships, and in Vitro Pharmacology.
    Pallesen J; Møllerud S; Frydenvang K; Pickering DS; Bornholdt J; Nielsen B; Pasini D; Han L; Marconi L; Kastrup JS; Johansen TN
    ACS Chem Neurosci; 2019 Mar; 10(3):1841-1853. PubMed ID: 30620174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neto proteins regulate gating of the kainate-type glutamate receptor GluK2 through two binding sites.
    Li YJ; Duan GF; Sun JH; Wu D; Ye C; Zang YY; Chen GQ; Shi YY; Wang J; Zhang W; Shi YS
    J Biol Chem; 2019 Nov; 294(47):17889-17902. PubMed ID: 31628192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signal peptide represses GluK1 surface and synaptic trafficking through binding to amino-terminal domain.
    Duan GF; Ye Y; Xu S; Tao W; Zhao S; Jin T; Nicoll RA; Shi YS; Sheng N
    Nat Commun; 2018 Nov; 9(1):4879. PubMed ID: 30451858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.